Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
AstraZeneca
Express Scripts
Baxter
McKesson

Last Updated: November 27, 2022

CLINICAL TRIALS PROFILE FOR PREDNISOLONE ACETATE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Prednisolone Acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00134992 ↗ A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers Completed Novartis Phase 4 2004-08-01 The objective of this trial was to confirm the tolerability of prednisolone acetate 0.5% eye drops by testing the hypothesis that the ocular safety and tolerability of prednisolone acetate 0.5% eye drops are equivalent to vehicle. Thus healthy volunteers have been selected and have been treated by using a crossover design.
NCT00170729 ↗ A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery Completed Novartis Phase 4 2004-08-17 The primary objective was to demonstrate that two days of treatment with 0.5% prednisolone acetate eye-drops after cataract surgery are superior to vehicle in reducing the flare in the anterior chamber of the operated eye.
NCT00198523 ↗ A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte Completed Bausch & Lomb Incorporated Phase 3 2005-07-01 The purpose of this study is to demonstrate the bioequivalence of the combination test agent, prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension compared to PredForte (prednisolone acetate 1.0%) ophthalmic suspension. Bioequivalence will be measured by comparing aqueous humor concentrations of prednisolone acetate.
NCT00229918 ↗ PST/Laser v. Laser Alone for CSME Unknown status Edward Hines Jr. VA Hospital Phase 2 2005-09-01 Prospective randomized clinical trial comparing Laser Alone v. Laser and posterior sub-tenon injection of triamcinolone acetonide for primary and refractory clinically significant macular edema.
NCT00238563 ↗ Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery Withdrawn Stanford University N/A 1969-12-31 Determine efficacy of sub tenon kenalog injections for post-operative management of trabeculectomy procedures.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Prednisolone Acetate

Condition Name

Condition Name for Prednisolone Acetate
Intervention Trials
Cataract 14
Glaucoma 5
Prostatic Neoplasms 4
Cataracts 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Prednisolone Acetate
Intervention Trials
Cataract 28
Inflammation 21
Prostatic Neoplasms 15
Macular Edema 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Prednisolone Acetate

Trials by Country

Trials by Country for Prednisolone Acetate
Location Trials
United States 221
Japan 31
Germany 23
Italy 21
United Kingdom 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Prednisolone Acetate
Location Trials
New York 22
California 18
Massachusetts 12
Florida 11
Texas 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Prednisolone Acetate

Clinical Trial Phase

Clinical Trial Phase for Prednisolone Acetate
Clinical Trial Phase Trials
Phase 4 46
Phase 3 20
Phase 2/Phase 3 7
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Prednisolone Acetate
Clinical Trial Phase Trials
Completed 49
Recruiting 23
Unknown status 7
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Prednisolone Acetate

Sponsor Name

Sponsor Name for Prednisolone Acetate
Sponsor Trials
Ocular Therapeutix, Inc. 12
Janssen Research & Development, LLC 6
Alcon Research 5
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Prednisolone Acetate
Sponsor Trials
Other 70
Industry 61
NIH 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
Mallinckrodt
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.